COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 3008: Articles 30071-30080  | Next

A snapshot of SARS-CoV-2 genome availability up to 30th March, 2020 and its implications
Mavian, C., Marini, S., Prosperi, M., Salemi, M.
10.1101/2020.04.01.020594 — Posted: 2020-04-05
Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2
Chu, P., Zhou, Z., Gao, Z., Cai, R., Wu, S., Sun, Z., Chen, S., Yang, Y.
10.1101/2020.04.04.025080 — Posted: 2020-04-05 Discussion: Onsite
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
Dinesh, D. C., Chalupska, D., Silhan, J., Veverka, V., Boura, E.
10.1101/2020.04.02.022194 — Posted: 2020-04-05
Coronavirus hemagglutinin-esterase and spike proteins co-evolve for functional balance and optimal virion avidity
Lang, Y., Li, W., Li, Z., Koerhuis, D., van den Burg, A. C. S., Rozemuller, E., Bosch, B.-J., van Kuppeveld, F. J. M., Boons, G.-J. P. H., Huizinga, E. G., van der Schaar, H. M., de Groot, R. J.
10.1101/2020.04.03.003699 — Posted: 2020-04-05
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Touret, F., Gilles, M., Barral, K., Nougairede, A., Decroly, E., de Lamballerie, X., Coutard, B.
10.1101/2020.04.03.023846 — Posted: 2020-04-05 Discussion: Onsite
Analytical Validation of a COVID-19 qRT-PCR Detection Assay Using a 384-well Format and Three Extraction Methods
Nelson, A. C., Auch, B., Schomaker, M., Gohl, D. M., Grady, P., Johnson, D., Kincaid, R., Karnuth, K. E., Daniel, J., Fiege, J. K., Fay, E. J., Bold, T., Langlois, R. A., Beckman, K. B., Yohe, S.
10.1101/2020.04.02.022186 — Posted: 2020-04-05 Discussion: Offsite
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., Dong, Y.
10.1101/2020.04.01.019877 — Posted: 2020-04-05
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Sawalha, A. H., Zhao, M., Coit, P., Lu, Q.
10.1101/2020.03.30.20047852 — Posted: 2020-04-04 Discussion: Offsite
Modeling the COVID-19 outbreaks and the effectiveness of the containment measures adopted across countries
De Brouwer, E., Raimondi, D., Moreau, Y.
10.1101/2020.04.02.20046375 — Posted: 2020-04-04 Discussion: Onsite
Single-cell RNA Analysis on ACE2 Expression Provides Insight into SARS-CoV-2 Blood Entry and Heart Injury
Guo, J., Wei, X., Li, Q., Li, L., Yang, Z., Shi, Y., Qin, Y., Zhang, X., Wang, X., Zhi, X., Meng, D.
10.1101/2020.03.31.20047621 — Posted: 2020-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).